glp-1/fgf21 agonist boehringer Safety and efficacy of dual HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study Novel Therapies for Cardiometabolic Disease:
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3


























